Centogene NV (Centogene NV) Total Stockholders Equity : $-16.49 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Centogene NV Total Stockholders Equity?

Centogene NV's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $-16.49 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Centogene NV's Book Value per Share for the quarter that ended in Jun. 2023 was $-0.59. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Centogene NV's Debt-to-Equity for the quarter that ended in Jun. 2023 was -3.94.

Centogene NV Total Stockholders Equity Historical Data

The historical data trend for Centogene NV's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV Total Stockholders Equity Chart

Centogene NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

31.04

66.51

78.87

30.58

7.85

Centogene NV Quarterly Data
	Dec17	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Total Stockholders Equity	Get a 7-Day Free Trial															30.58	35.89	22.31	7.85	-16.49

Centogene NV (NAS:CNTG) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Centogene NV's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-16.492	-	0)	/	27.8657
	=	-0.59

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Centogene NV's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(7.38	+	57.522)	/	-16.492
	=	-3.94

Centogene NV Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Centogene NV's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Centogene NV (Centogene NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (NAS:CNTG) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

39K:Germany

Address

Am Strande 7, Rostock, MV, DEU, 18055

Website

https://www.centogene.com

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.